AAAAAA
Results:
1-14
|
Results: 14
Authors:
de Wit, R
Roberts, JT
Wilkinson, PM
de Mulder, PHM
Mead, GM
Fossa, SD
Cook, P
de Prijck, L
Stenning, S
Collette, L
Citation: R. De Wit et al., Equivalence of three or four cycles of bleomycin, etoposide, and cisplatinchemotherapy and of a 3- or 5-day schedule in good-prognosis germ cell cancer: A randomized study of the European organization for research and treatment of cancer genitourinary tract cancer cooperative group and the medicalresearch council, J CL ONCOL, 19(6), 2001, pp. 1629-1640
Authors:
Gale, J
Simmonds, PD
Mead, GM
Sweetenham, JW
Wright, DH
Citation: J. Gale et al., Enteropathy-type intestinal T-cell lymphoma: Clinical features and treatment of 31 patients in a single center, J CL ONCOL, 18(4), 2000, pp. 795-803
Authors:
Mead, GM
Citation: Gm. Mead, Failure of named representatives in a class action to satisfy the statute of limitations, UNIV CHIC L, 67(3), 2000, pp. 805-834
Authors:
Mead, GM
Bleehen, NM
Gregor, A
Bullimore, J
Murrell, DS
Rampling, RP
Roberts, JT
Glaser, MG
Lantos, P
Ironside, JW
Moss, TH
Brada, M
Whaley, JB
Stenning, SP
Citation: Gm. Mead et al., A medical research council randomized trial in patients with primary cerebral non-Hodgkin lymphoma - Cerebral radiotherapy with and without cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy, CANCER, 89(6), 2000, pp. 1359-1370
Authors:
Horwich, A
Oliver, RTD
Wilkinson, PM
Mead, GM
Harland, SJ
Cullen, MH
Roberts, JT
Fossa, SD
Dearnaley, DP
Lallemand, E
Stenning, SP
Citation: A. Horwich et al., A Medical Research Council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma, BR J CANC, 83(12), 2000, pp. 1623-1629
Authors:
Lawton, AJ
Mead, GM
Citation: Aj. Lawton et Gm. Mead, Staging and prognostic factors in testicular cancer, SEM SURG ON, 17(4), 1999, pp. 223-229
Authors:
Collette, L
Sylvester, RJ
Stenning, SP
Fossa, SD
Mead, GM
de Wit, R
de Mulder, PHM
Neymark, N
Lallemand, E
Kaye, SB
Citation: L. Collette et al., Impact of the treating institution on survival of patients with "poor-prognosis" metastatic nonseminoma, J NAT CANC, 91(10), 1999, pp. 839-846
Authors:
Mead, GM
Citation: Gm. Mead, Who should manage germ cell tumours of the testis?, BJU INT, 84(1), 1999, pp. 61-67
Authors:
Lee, AHS
Mead, GM
Theaker, JM
Citation: Ahs. Lee et al., The value of central histopathological review of testicular tumours beforetreatment, BJU INT, 84(1), 1999, pp. 75-78
Authors:
Dunsford, ML
Mead, GM
Bateman, AC
Cook, T
Tung, K
Citation: Ml. Dunsford et al., Severe pulmonary toxicity in patients treated with a combination of docetaxel and gemcitabine for metastatic transitional cell carcinoma, ANN ONCOL, 10(8), 1999, pp. 943-947
Authors:
Ritchie, A
Griffiths, G
Parmar, M
Fossa, SD
Selby, PJ
Cornbleet, MA
Sibley, G
Mead, GM
Kaye, S
Owen, JR
Oliver, RTD
Smith, PH
Whelan, P
Cook, PA
Fayers, PM
Cook, P
Webb, J
Whitehead, J
Lamont, A
Citation: A. Ritchie et al., Interferon-alpha and survival in metastatic renal carcinoma: early resultsof a randomised controlled trial, LANCET, 353(9146), 1999, pp. 14-17
Authors:
Hassan, B
Tung, K
Weeks, R
Mead, GM
Citation: B. Hassan et al., The management of inferior vena cava obstruction complicating metastatic germ cell tumors, CANCER, 85(4), 1999, pp. 912-918
Authors:
Fossa, SD
Bokemeyer, C
Gerl, A
Culine, S
Jones, WG
Mead, GM
Germa-Luch, JR
Pont, J
Schmoll, HJ
Tjulandin, S
Citation: Sd. Fossa et al., Treatment outcome of patients with brain metastases from malignant germ cell tumors, CANCER, 85(4), 1999, pp. 988-997
Authors:
Fossa, SD
Stenning, SP
Gerl, A
Horwich, A
Clark, PI
Wilkinson, PM
Jones, WG
Williams, MV
Oliver, RT
Newlands, ES
Mead, GM
Cullen, MH
Kaye, SB
Rustin, GJS
Cook, PA
Citation: Sd. Fossa et al., Prognostic factors in patients progressing after cisplatin based chemotherapy for malignant non-seminomatous germ cell tumours, BR J CANC, 80(9), 1999, pp. 1392-1399
Risultati:
1-14
|